TITLE

Biotech in boom cycle

AUTHOR(S)
Baker, John
PUB. DATE
April 2007
SOURCE
ICIS Chemical Business;4/23/2007, Vol. 2 Issue 63, p36
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the growth of Europe's biotechnology industry as of April 23, 2007. Biotechnology revenues grew by 13% to €13.3bn ($18.1bn) in 2006, sustaining the momentum the sector began to display in 2005 after two years of contraction. Globally, revenues from publicly traded biotechnology companies rose by 14% in 2006 to reach $73.4bn (€54.1bn). Financing increased by 45% to €4.7bn, with venture capital financing at an all-time high of €1.5bn.
ACCESSION #
24983138

 

Related Articles

  • No magic potion. Dietderich, Andrew; Bailey, Laura // Crain's Detroit Business;6/24/2002, Vol. 18 Issue 25, p3 

    Focuses on the initiatives of life-science companies to confront with the slow economy in Michigan. Extent of competition for funding in the industry; Assessment on the survival of the companies; Advantages of small and large companies in the industry.

  • FINANCINGS ROUNDUP.  // BioWorld Today;2/22/2010, Vol. 21 Issue 34, p7 

    This section offers news briefs on financing for the biotechnology industry, including a grant from the BuiCrossroads Indiana Seed Fund to Bioscience Vaccines Inc., the exercise of the overallotment option by underwriters of its public offering of stock and warrants and an at-the-market program...

  • Financings Roundup.  // BioWorld Today;9/29/2010, Vol. 21 Issue 188, p8 

    This section offers news briefs on financing activities in the biotechnology industry, including the Horizon Discovery Ltd. Seriec C financing, Titan Pharmaceuticals Inc.'s amended loan and security agreement with Oxford Finance Corp., and Tigris Pharmaceuticals Inc.'s private placement of...

  • Cash-strapped firms face stormy time. Mitchell, Peter // Nature Biotechnology;Jan2002, Vol. 20 Issue 1, p5 

    Reports that a significant number of European biotechnology companies are in danger of closing within a year unless they can reinvent their business plans and raise new cash, according to a consensus of industry observers. Reasons why investors abandon early-stage companies; European companies...

  • FINANCINGS ROUNDUP.  // BioWorld Today;2/26/2010, Vol. 21 Issue 38, p7 

    This section offers finance-related news briefs within the biotechnology industry including the decision of Palatin Technologies Inc. to sell common stock in a registered direct offering and the increase in Trius Therapeutics Inc.'s proposed initial public offering to fund Phase III trials of an...

  • Coming Monday in BioWorld Insight.  // BioWorld Today;3/15/2013, Vol. 24 Issue 50, p7 

    The section offers news briefs related to the biotechnology industry as of March 15, 2013 including one on the multiple strategies used by large pharmaceutical companies to build early stage pipelines, one on an anti-age old debate over Sirtuin research, and one on biotech companies targeting to...

  • Bubble, Bubble, Toil and Trouble. Boorstin, Julia // Fortune;6/11/2001, Vol. 143 Issue 12, p48 

    Discusses the financial status of biotechnology companies in the United States. Drop in the share prices of the companies; How many continue to attract venture capital; Opinion that many have enough money to survive the economic downturn; Suggestion that companies that can not survive will be...

  • Financings Roundup.  // BioWorld Today;5/22/2012, p8 

    This section offers news briefs on financing for biotechnology companies, including the second closing of the Series B round of financing of Prosonix Ltd. of Great Britain which raised an additional 5.7 million British pounds.

  • Biotech companies cash in on 'Year of the Genome' Crabtree, Penni // Fairfield County Business Journal;01/29/2001, Vol. 40 Issue 5, p3 

    Focuses on an investment frenzy in the field of biotechnology in the United States. Hoopla from completion of the first rough map of the human genome; Amount of money raised by public and private biotechnology companies during the first quarter of 2000.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics